Tag: avodart
-
5-ARI delays prostate cancer progression in men with low-risk disease – ModernMedicine
The 5-alpha-reductase inhibitor dutasteride Avodart appears to delay disease progression and the initiation of active treatment in men with low-risk, localized prostate cancer, results of a 3-year international clinical trial indicate.Treatment with dutasteride also reduces cancer-related anxiety, study authors found.”The results prove that using active surveillance plus dutasteride is a viable, safe, and effective treatment…
-
Dutasteride Slows Prostate Cancer Progression – Renal and Urology News
ORLANDO—Dutasteride, a drug widely prescribed for treating benign prostatic enlargement, lowers the risk of prostate cancer PCa progression in men undergoing active surveillance for the disease, researchers concluded. via Dutasteride Slows Prostate Cancer Progression – Renal and Urology News. Dutasteride has been used for BPH and is thought to help reduce the risk of developing…
-
FDA committee votes down 5-ARIs for prostate cancer risk reduction – – UrologyTimes
“Although the REDUCE trial demonstrated a risk reduction in a large number of men, the committee chose to focus on a small number of high-grade cancers and determined that this class of drugs is inappropriate for prostate cancer risk reduction, even in the population of men with elevated PSA and previous negative biopsy,” added Dr.…